Aaron Goldman Builds Bridges to Advance Drug Development
With his lab’s new collaboration with a biotechnology company, Aaron Goldman, PhD, is tackling the problem of drug efficacy head-on.
SPORE Collaboration Plants the Seed for Cancer Drug Approval
A newly approved drug for treating pediatric brain tumors is the latest example of a clinical advancement that has sprung from a multi-institutional collaboration spanning labs and clinics at Mass General Brigham, Dana-Farber Cancer Institute, Boston Children’s Hospital, and the University of California, San Francisco.
Unveiling the Secrets of TIM-3
The road to a potential new drug for treating cancer-related conditions began with a basic research question in the Kuchroo lab
Focused Ultrasound Technology Offers Novel Path to Deliver Drugs to the Brain
The Focused Ultrasound (FUS) lab of the Brigham Department of Radiology is perfecting an ultrasound technology to deliver gene therapies to tissues deep in the brain with precision while clinicians in the Department of Neurosurgery have completed a clinical trial testing the technology
Engineering Better Ways to Deliver Drug Therapies
Natalie Artzi, PhD, and her team of researchers are designing smart biomaterials to deliver on the next generation of therapies
Insights from the Lab Lead to a New Approach to Reversing Hearing Loss
Jeff Karp, PhD, and his team have journeyed from researching how the human intestinal lining regenerates to identifying small molecules that may restore lost hearing
Delivering on the Promise of Long-Lasting Pills
Gastroenterologist and innovator Giovanni Traverso, MB, BChir, PhD, and his colleagues founded Lyndra Therapeutics seven years ago; today, they are closer than ever before to providing medications to patients in a capsule that can be taken just once a week or month